Recent advances in intraocular sustained-release drug delivery devices.
Recent advances in intraocular sustained-release drug delivery devices.
Drug Discov Today. 2019 Jun 04;:
Authors: Cao Y, Samy KE, Bernards DA, Desai TA
Abstract
Topical eye-drop administration and intravitreal injections are the current standard for ocular drug delivery. However, patient adherence to the drug regimen and insufficient administration frequency are well-documented challenges to this field. In this review, we describe recent advances in intraocular implants designed to deliver therapeutics for months to years, to obviate the issues of patient adherence. We highlight recent advances in monolithic ocular implants in the literature, the commercialization pipeline, and approved for the market. We also describe design considerations based on material selection, active pharmaceutical ingredient, and implantation site.
PMID: 31173915 [PubMed - as supplied by publisher]
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Cao Y, Samy KE, Bernards DA, Desai TA Tags: Drug Discov Today Source Type: research
More News: Drugs & Pharmacology